Andrew Reardon
CLO & Secretary at Ligand Pharmaceuticals. Based in Palm Beach Gardens, Florida.
- Rank
- 9379th of 14,644
- Companies held
- 1
- Largest holding
- LGND, 100.0% of total
- Latest SEC filing
- Nov 2, 2026
What the $9.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 31,854 | $286.94 | $9.1M | 100.0% | Form 4, Nov 2, 2026 |
Share counts are the amounts Andrew Reardon reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Sold | LGND | 283 | $307.39 | $87K | View |
| Nov 2, 2026 | Sold | LGND | 708 | $308.43 | $218K | View |
| Nov 2, 2026 | Sold | LGND | 522 | $309.91 | $162K | View |
| Nov 2, 2026 | Sold | LGND | 490 | $310.61 | $152K | View |
| Nov 2, 2026 | Sold | LGND | 520 | $311.72 | $162K | View |
| Nov 2, 2026 | Sold | LGND | 634 | $312.85 | $198K | View |
| Nov 2, 2026 | Sold | LGND | 403 | $313.75 | $126K | View |
| Nov 2, 2026 | Sold | LGND | 80 | $314.58 | $25K | View |
| Nov 2, 2026 | Sold | LGND | 280 | $317.91 | $89K | View |
| Nov 2, 2026 | Sold | LGND | 440 | $318.73 | $140K | View |
| Nov 2, 2026 | Sold | LGND | 320 | $319.97 | $102K | View |
| Nov 2, 2026 | Sold | LGND | 200 | $321.44 | $64K | View |
| Nov 2, 2026 | Sold | LGND | 120 | $323.14 | $39K | View |
| Oct 2, 2026 | Sold | LGND | 833 | $302.51 | $252K | View |
| Oct 2, 2026 | Sold | LGND | 1,976 | $303.54 | $600K | View |
| Oct 2, 2026 | Sold | LGND | 1,535 | $304.52 | $467K | View |
| Oct 2, 2026 | Sold | LGND | 404 | $306.18 | $124K | View |
| Oct 2, 2026 | Sold | LGND | 235 | $307.19 | $72K | View |
| Oct 2, 2026 | Sold | LGND | 17 | $307.74 | $5K | View |
| Sep 3, 2026 | Sold | LGND | 385 | $287.53 | $111K | View |
| Sep 3, 2026 | Sold | LGND | 1,800 | $285.17 | $513K | View |
| Sep 3, 2026 | Sold | LGND | 2,115 | $286.36 | $606K | View |
| Sep 3, 2026 | Sold | LGND | 300 | $283.99 | $85K | View |
| Sep 3, 2026 | Sold | LGND | 400 | $288.98 | $116K | View |
| Aug 3, 2026 | Sold | LGND | 200 | $290.60 | $58K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9376 | Stephen R. Springer Director, Atmos Energy. Dallas, TX | $9.1M |
| 9377 | Bashir El-Rufai Director, IHS Holding | $9.1M |
| 9378 | Thomas W. Rabaut Director, Allison Transmission Holdings. Indianapolis, IN | $9.1M |
| 9379 | Andrew Reardon CLO & Secretary, Ligand Pharmaceuticals. Palm Beach Gardens, FL | $9.1M |
| 9380 | Adam Wyll President & CEO, American Assets Trust. San Diego, CA | $9.1M |
| 9381 | Peter S. Norgeot Jr. EVP & Chief Operating Officer, Entergy. New Orleans, LA | $9.1M |
| 9382 | Danny R. McPherson EVP - Technology & CSO, VeriSign. Reston, VA | $9.1M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1498 overall
- Todd C. Davis$57.2MChief Executive Officer. #1695 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
Questions
How much stock does Andrew Reardon own?
Andrew Reardon holds $9,140,187 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 9379th on the Stock Rich List.
Is this Andrew Reardon's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Andrew Reardon last buy or sell stock?
The most recent open-market trade on file is a sale of 283 LGND shares on Nov 2, 2026 at $307.39.